[1] |
Liu Yanfei, Li Tao, Xia Yinyin, Zhu He, Zhao Yanlin, Chen Wei.
Analysis of average hospitalization costs and factors affecting extrapulmonary tuberculosis and tuberculous pleurisy patients in designated tuberculosis hospitals, 2018—2020
[J]. Chinese Journal of Antituberculosis, 2024, 46(5): 509-518.
|
[2] |
Yang Jing, Xiao Lijuan, Fang Tanwei.
Development strategy and prospect of tuberculosis mRNA vaccines
[J]. Chinese Journal of Antituberculosis, 2024, 46(5): 590-595.
|
[3] |
Li Junli, Guo Xiaonan, Liang Yan, He Pu, Li Xiaochi, Zhao Aihua, Du Weixin, Wu Xueqiong, Zhu Bingdong, Xu Miao.
Research advances and breakthroughs in tuberculosis vaccine
[J]. Chinese Journal of Antituberculosis, 2024, 46(10): 1171-1184.
|
[4] |
Ding Qin, Chen Wei, Zhang Shengkang, Ren Fei, Chen Xiaohong, Hu Chunmei, Chen Danping, Fan Lin.
Investigation of nutritional status and analysis of influencing factors in patients with extrapulmonary tuberculosis
[J]. Chinese Journal of Antituberculosis, 2023, 45(9): 839-844.
|
[5] |
Shang Yaomin, Zhou Xiaolei, Xue Yunling, Leng Xia.
Effect of microcard combined with vitamin D on the balance of CD4+ T cell subsets in initially treated patients with smear positive pulmonary tuberculosis
[J]. Chinese Journal of Antituberculosis, 2023, 45(6): 575-582.
|
[6] |
Zhang Mengxian, Wang Ni, Huang Fei, Zhou Liping, Zhao Yanlin.
Landscape and prospect of tuberculosis vaccine research and development in China
[J]. Chinese Journal of Antituberculosis, 2023, 45(2): 125-129.
|
[7] |
Dong Jiaxin, Zhao Aihua, Xia Huanzhang, Xu Miao.
Interpretation and reflection on the WHO Preferred Product Characteristics for New Tuberculosis Vaccines
[J]. Chinese Journal of Antituberculosis, 2023, 45(11): 1016-1020.
|
[8] |
Yang Zhenggui, Jiang Zeshun, Liu Lan, Han Xue.
Effect of Mycobacterium vaccinae on T Lymphocyte subsets in peripheral blood of HIV patients complicated with latent Mycobacterium tuberculosis infection
[J]. Chinese Journal of Antituberculosis, 2023, 45(10): 925-931.
|
[9] |
LIU Li-qin, XU Zu-hui, HUANG Yi-sheng, YAO Qi-neng, TAN Yun-hong, ZHOU Lin, XIA Yin-yin, LIU Er-yong, HUANG Guo-jun, BAI Li-qiong, CHENG Shi-ming.
Study on the clinical efficacy of a 4-month treatment program for the initial treatment of smear-negative pulmonary tuberculosis with Mycobacterium vaccae Vaccine immune intervention
[J]. Chinese Journal of Antituberculosis, 2022, 44(2): 125-130.
|
[10] |
Cao Fu, Ma Xiaohong, Ma Tian, Luo Jian, Zhong Xinxin, Feng Junlan, Li Xiaojuan, Liang Zhengen, Zhang Qizhen.
Effects of meteorological factors and air pollutants on the incidence of pulmonary tuberculosis in Yulin from 2017 to 2021
[J]. Chinese Journal of Antituberculosis, 2022, 44(11): 1154-1161.
|
[11] |
CAO Qian-qian, ZHU Bing-dong, NIU Hong-xia.
Research progress on recombinant protein subunit vaccine of tuberculosis
[J]. Chinese Journal of Antituberculosis, 2021, 43(9): 970-974.
|
[12] |
WANG Yuan-zhi, LIANG Zheng-min, QU Meng-jin, ZHOU Xiang-mei.
Research progress of tuberculosis vaccine and vaccination strategy
[J]. Chinese Journal of Antituberculosis, 2021, 43(6): 625-630.
|
[13] |
LIU Er-yong, LI Yu-hong, ZHOU Lin, ZHAO Yan-lin.
Making panoramic plan:extra-pulmonary tuberculosis needs to be integrated into the national tuberculosis program
[J]. Chinese Journal of Antituberculosis, 2021, 43(5): 428-431.
|
[14] |
LIANG Rui-yun, FANG Wei-jun, REN Hui-li, LI Hui-ru, ZHANG Hui, LI Cheng-cheng.
Analysis of CT features of drug-resistant pulmonary tuberculosis with cavity
[J]. Chinese Journal of Antituberculosis, 2021, 43(4): 341-345.
|
[15] |
WANG Mei-jie, LI Yu-ze, XIAO Yao, WU Ming-qi, HOU Shao-ying.
A comparative study of plasma metabolomics between diabetes and diabetes complicated with pulmonary tuberculosis
[J]. Chinese Journal of Antituberculosis, 2021, 43(1): 36-41.
|